Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/26/2008

t and planned preclinical studies and clinical trials; our ability to successfully manufacture our products and product candidates; the content and timing of decisions by the U.S. Food and Drug Administration, the European Commission and other regulatory authorities concerning each of the described products and product candidates; the market for each of these products and particularly Aldurazyme, Naglazyme and Kuvan; actual sales of Aldurazyme, Naglazyme and Kuvan; Merck Serono's activities related to Kuvan; and those factors detailed in BioMarin's filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's 2006 Annual Report on Form 10-K, as amended, and the factors contained in BioMarin's reports on Form 10-Q and Form 8-K. Stockholders are urged not to place undue reliance on forward-looking statements, which speak only as of the date hereof. BioMarin is under no obligation, and expressly disclaims any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise.

BioMarin(R) and Naglazyme(R) are a registered trademarks of BioMarin Pharmaceutical Inc.

Aldurazyme(R) is a registered trademark of BioMarin/Genzyme LLC.

Orapred(R) is a registered trademark of Medicis Pediatrics, Inc. and is used under license.

Contact:

Investors Media

Eugenia Shen Susan Berg

BioMarin Pharmaceutical Inc. BioMarin Pharmaceutical Inc.

(415) 506-6570 (415) 506-6594
Net Product Revenue of BioMarin Pharmaceutical Inc. and BioMarin/Genzyme LLC

For the Three Months and Years Ended December 31, 2006 and 2007

(In millions, unaudited)

Three Months Year Ended


'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. BioMarin to Present at the BioCentury NewsMakers Conference
3. BioMarin to Present at the Rodman & Renshaw 9th Annual Healthcare Conference
4. BioMarin and IGAN Biosciences to Collaborate on Development of an Enzyme Therapy to Treat IgA Nephropathy, a Rare and Life-Threatening Kidney Disease
5. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
6. BioMarin Appoints Dr. Gordon Vehar, Vice President of Research
7. BioMarin to Present at the Merrill Lynch 2008 Global Healthcare Conference
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... New York , July 31, 2014 ... by Transparency Market Research "Electrodes for Medical Devices Market ... Scalp Electrodes, Therapeutic Electrodes - TENS, Pacemakers, Defibrillators, Electrosurgical ... Growth, Trends and Forecast, 2013 - 2019," the global ... 633.6 million in 2012 and is estimated to reach ...
(Date:7/31/2014)... CollabRx, Inc. (NASDAQ: CLRX), a leading provider ... today announced that it will hold an investor conference ... financial results for the first quarter of fiscal 2015 ... the current fiscal year. , The dial-in number for ... 2014, at 5 p.m. EDT (2 p.m. PDT) is ...
(Date:7/31/2014)... 31, 2014  Smith & Nephew (LSE:SN, NYSE: ... business, today announced its entry into the forefoot ... Toe Repair System. Comprised of three separate repair ... (MTP) ligament repair and reconstruction, a metatarsal osteotomy ... Inter-phalanges (PIP) fusion, also known as hammer toe ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Held at ... patients with an overview of the disease and its ... drug side effects, as well as updates on the ... to Dr. Sandy Srinivas for organizing this educational opportunity,” ... kidney cancer. “Sandy and her colleagues have put together ...
Breaking Biology Technology:Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 2Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 3Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 4Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 5Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 6CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 3Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 4
... CITY, Calif., Feb. 23, 2011 Ingenuity® Systems, ... for life science researchers, today announced a research ... for next-generation sequencing (NGS) data analysis. Covance Genomics ... the drug discovery and development industry, and Ingenuity ...
... Carolina State University have developed a faster, easier ... devices, by using liquid metal. Microfluidic devices manipulate ... variety of applications, from testing minute blood samples ... it easier to incorporate electrodes into microfluidic devices, ...
... Fla., Feb. 22, 2011 Dyadic International, Inc. ("Dyadic") ... the discovery, development, manufacture and sale of enzyme and ... industries, announced today that it has launched FibreZyme® ... to improve paper quality and improve the economics of ...
Cached Biology Technology:Ingenuity Systems and Covance Collaborate to Support Next-Generation Sequencing Research 2Liquid metal key to simpler creation of electrodes for microfluidic devices 2Dyadic International Launches High Performance Enzyme for Pulp and Paper Industry Using New C1 Production Platform 2
(Date:7/31/2014)... familiar with Hibiscus flowers- they are an iconic ... commonly planted in the landscape. Some, like Hawaii,s ... species. , Only a relatively few botanists and ... equally beautiful and intriguing related group of plants ... Hibiscus". , Brother of Hibiscus species are in ...
(Date:7/31/2014)... studies have shown that marine noise can affect animal ... the Universities of Bristol and Exeter and the cole ... demonstrated that boat noise stops embryonic development and increases ... the sea slug Stylocheilus striatus used in ... away and later feed on toxic alga but this ...
(Date:7/30/2014)... eggs until they hatched 4.5 years later, according to ... journal PLOS ONE by Bruce Robison from ... typically have a single reproductive period during their life, ... fertilized eggs until they hatch. Shallow-water octopuses typically care ... little is known about the brooding of deep-sea species. ...
Breaking Biology News(10 mins):Brother of Hibiscus is found alive and well on Maui 2Boat noise impacts development and survival of sea hares 2Deep-sea octopus has longest-known egg-brooding period 2
... LaserCard Launches ID Badge Fulfillment Service, MOUNTAIN ... LCRD ) and Tesla Motors announce the successful,implementation ... for Tesla,s corporate headquarters in San Carlos, California. ... as the supplier,and prime contractor for the design ...
... be the Latest Addition to M2SYS, ... Biometric ... biometric,technology research and development firm, announced today its partnership,with SecuGen ... The Hamster Plus fingerprint reader features innovative Auto-On,technology that automatically ...
... earnings and deepens customer relationships, WALL, N.J., ... BKYI), a leader in wireless public safety and,finger-based ... the second quarter ended June 30, 2007. ... months ended,June 30, 2007 decreased 19% to $2.5 ...
Cached Biology News:Silicon Valley Technology Leaders LaserCard Corporation and Tesla Motors Sign LaserPass Secure Access Deal 2Silicon Valley Technology Leaders LaserCard Corporation and Tesla Motors Sign LaserPass Secure Access Deal 3M2SYS Partners with SecuGen Corporation to Support Market Leading Hamster Plus Fingerprint Reader with Auto-On Technology 2BIO-key Reports Second Quarter 2007 Results 2BIO-key Reports Second Quarter 2007 Results 3BIO-key Reports Second Quarter 2007 Results 4BIO-key Reports Second Quarter 2007 Results 5
... The Multiple Species Tissue Array (MSTA) slides were ... cells and tissues from multiple species. Tissue ... each MSTA slide which can then be treated ... immunohistochemistry, or in situ hybridization. ...
... Pulser Xcell eukaryotic system, 100 ... is used for electroporation of ... the main unit, CE module ... or square-wave pulses, ShockPod shocking ...
... WinMelt software is used ... of any DNA sequence up ... in optimizing placement of primers ... detection by denaturing gradient gel ...
AVOID FREEZE/THAW CYCLES. Recognizes the ~5 kDa thymosin beta4 protein....
Biology Products: